1. Hald, S. et al. Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study. PLoS One 11, e0159223 (2016).
2. Bindels, L. B. et al. Resistant starch can improve insulin sensitivity independently of the gut microbiota. Microbiome 5, 12 (2017).
3. Marlatt, K. L. et al. Role of resistant starch on diabetes risk factors in people with prediabetes: Design, conduct, and baseline results of the STARCH trial. Contemp. Clin. Trials 65, 99–108 (2018).
4. Peterson, C. M. et al. Effect of 12 wk of resistant starch supplementation on cardiometabolic risk factors in adults with prediabetes: a randomized controlled trial. Am. J. Clin. Nutr. (2018). doi:10.1093/ajcn/nqy121
5. Upadhyaya, B. et al. Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions. Sci. Rep. 6, 28797 (2016).
6. Dainty, S. A. et al. Resistant Starch Bagels Reduce Fasting and Postprandial Insulin in Adults at Risk of Type 2 Diabetes. J. Nutr. 146, 2252–2259 (2016).
7. Karimi, P. et al. The Therapeutic Potential of Resistant Starch in Modulation of Insulin Resistance, Endotoxemia, Oxidative Stress and Antioxidant Biomarkers in Women with Type 2 Diabetes: A Randomized Controlled Clinical Trial. Ann. Nutr. Metab. 68, 85–93 (2016).
8. Alfa, M. J. et al. A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults. Front. Med. 4, 260 (2018).
9. Sandberg, J. C., Björck, I. M. E. & Nilsson, A. C. Effects of whole grain rye, with and without resistant starch type 2 supplementation, on glucose tolerance, gut hormones, inflammation and appetite regulation in an 11-14.5 hour perspective; a randomized controlled study in healthy subjects. doi:10.1186/s12937-017-0246-5